Amneal Pharmaceuticals Stock Quote AMRX - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

8.82

Bid

8.60

Ask

8.95

Volume

659,206

8.56 Day's Range 8.85

5.01 52 Week Range 8.94

Market Cap

2.73B

Previous Close

8.66

Open

8.64

Last Trade

8.5

Last Trade Time

Financial Volume

$ 5,785,948

VWAP

8.7771

Average Volume (3m)

1,274,019

Shares Outstanding

309,542,608

Dividend Yield

PE Ratio

-21.64

Earnings Per Share (EPS)

-0.27

Revenue

2.41B

Net Profit

-83.99M

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inha... Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.amneal.com

Headquarters

Wilmington, Delaware, USA

Founded

Amneal Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AMRX. The last closing price for Amneal Pharmaceuticals was $8.66. Over the last year, Amneal Pharmaceuticals shares have traded in a share price range of $ 5.01 to $ 8.94.

Amneal Pharmaceuticals currently has 309,542,608 shares outstanding. The market capitalization of Amneal Pharmaceuticals is $2.68 billion. Amneal Pharmaceuticals has a price to earnings ratio (PE ratio) of -21.64.

Amneal to Report Third Quarter 2024 Results on November 8, 2024

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) announced today that the Company will release its third quarter 2024 financial results on Friday, November 8, 2024, prior to market open. The Company...

Form 8-K - Current report

Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases

Amneal to construct state-of-the-art manufacturing facilities and utilize existing manufacturing network to ensure supply of Metsera’s portfolio of novel injectable and oral development programs...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.33	3.88692579505	8.49	8.82	8.425	714339	8.60829907	CS
4	0.02	0.227272727273	8.8	8.94	8.105	1074190	8.58145103	CS
12	1.37	18.389261745	7.45	8.94	6.5	1274019	8.11273341	CS
26	3.32	60.3636363636	5.5	8.94	5.18	1391086	7.20540337	CS
52	2.94	50	5.88	8.94	5.01	1438282	6.62312735	CS
156	2.94	50	5.88	8.94	5.01	1438282	6.62312735	CS
260	2.94	50	5.88	8.94	5.01	1438282	6.62312735	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DRUGBright Minds Biosciences Inc	$ 38.3976 (1,442.07%)	102.76M
NIVFNewGenIvf Group Ltd	$ 1.9501 (158.46%)	141.97M
ZPTAZapata Computing Holdings Inc	$ 0.1181 (53.38%)	558.35M
JDZGJIADE Ltd	$ 1.10 (46.65%)	24.5M
MRMMEDIROM Healthcare Technologies Inc	$ 3.69 (40.84%)	831.54k
SEELSeelos Therapeutics Inc	$ 1.26 (-48.57%)	1.7M
NTBLNotable Labs Ltd	$ 0.2688 (-32.80%)	1.92M
RANIRani Therapeutics Holdings Inc	$ 2.15 (-32.39%)	20.05M
YYAIConnexa Sports Technologies Inc	$ 4.14 (-30.88%)	396.94k
PIXYShiftPixy Inc	$ 7.03 (-27.23%)	1.02M
ZPTAZapata Computing Holdings Inc	$ 0.1181 (53.38%)	558.34M
NVDANVIDIA Corporation	$ 131.60 (-4.69%)	379.39M
GRTSGritstone bio Inc	$ 0.0687 (27.22%)	355.08M
SQQQProShares UltraPro Short QQQ	$ 7.28 (4.15%)	183.04M
NIVFNewGenIvf Group Ltd	$ 1.9501 (158.46%)	141.96M